CHRONIC HEPATITIS C (CHC)
Clinical trials for CHRONIC HEPATITIS C (CHC) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS C (CHC) trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS C (CHC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy shows promise against hepatitis c
Disease control CompletedThis study tested whether adding an experimental drug called MP-424 to two standard hepatitis C medications could better control the virus. It involved 54 adults with a specific type of hepatitis C who had never been treated or whose previous treatment had stopped working. The ma…
Matched conditions: CHRONIC HEPATITIS C (CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New combo therapy aims to knock out hepatitis c virus
Disease control CompletedThis study tested whether a three-drug combination (MP-424, interferon beta, and ribavirin) could successfully control Hepatitis C virus in people with specific strains of the disease. It involved 74 patients who were either new to treatment or had tried previous interferon-based…
Matched conditions: CHRONIC HEPATITIS C (CHC)
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC